BRANDKARMA THOUGHTS

Living with the promotional guidelines—one year later

It’s been a year since the introduction of the promotional guidelines prohibiting the distribution to healthcare professionals of pens, bags, and other “service items” bearing the product’s logo. So, how […]

Behind the Scenes

How about a little glimpse into the day-to-day of Core-Create? Sure, I could show you shots of all of us concepting; [...]

My Anti-social Media

Don’t get me wrong, I love it all, but I have to admit, I can’t get used to the amount of work it takes to keep up with the social media outlets I am interested in. [...]

Is the printed page dead?

I returned to my office after an extended business trip and was prepared to greet the foot-high stack of medical journals that would occupy my attention for the next week. [...]

Never Time to Do it Right

I have been quoted as saying that the quote made popular by our economic downturn—“now more than ever,” has been overused, and I admit I may be included in that group of over-users. As sick of the economy [...]

Should Agencies Issue RFCs?

Agencies have been grumbling about the client RFP process for years. And justifiably so as current RFP practices typically create an artificial environment where the agency is tested on its stamina and hunger for the business, and [...]

Can AHT be the new DTC?

The way things are going with our ability to effectively communicate with our prescription drug stakeholders, I think our business model is in for a big change. My clients—pharma, biotech […]

“Brandkarmantras”

The Brandkarmantra advocates 3 modalities to approach and manage any situation, task or obstacle. Using positive energy, we align everything we do with the creative power of the universe [...]

Data crunch vs. opportunity lost

I work in an industry that loves its data. I am a fan of data as well, but often I get a bit concerned that we have decided that data has taken the place of thinking [...]

Fighting fake drugs in Africa

It’s estimated that counterfeit pharmaceuticals comprise 10% of the global medicine trade. That number is much higher in developing nations, such as in Nigeria, where 50% - 70% of all drugs sold are counterfeits [...]